Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Patient-specific early classification of multivariate observations.
Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Antigen microarrays identify CNS-produced autoantibodies in RRMS.
Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis' views on risks of negative interactions between herbal medicine and conventional drug therapies.
Gait characteristics of multiple sclerosis patients in the absence of clinical disability.
Multiple perspectives on the health service need, use, and variability among older adults with multiple sclerosis.
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Preliminary Observations on Sensitivity and Specificity of Magnetization Transfer Asymmetry for Imaging Myelin of Rat Brain at High Field.
Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.
Preliminary Evidence of Increased Hippocampal Myelin Content in Veterans with Posttraumatic Stress Disorder.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
The Ins and Outs of B Cells in Multiple Sclerosis.
Microglia and astrocyte activation in the frontal cortex of rats with experimental autoimmune encephalomyelitis.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: Evidence for their involvement in regulation of the viral DNA replication.
Relation of Posterior Cerebellar Volume to Cognition in MS.
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Life-Span.
Proteomic analysis for early neurodegenerative biomarker detection in an animal model.
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.

Pages